What the sources say about breast augmentation prices in the US, UK, Germany and Turkey. The only official Turkish figure is a ministry tariff minimum for one procedure line; no citable package price exists, and the second bill after complications is the part least often quoted.
Researched with AI assistance; every figure is checked against the primary source cited on this page before publishing. How we work →
Each price below is labelled by what it actually is: advertised prices, a surgeon's fee, an NHS website estimate, or a ministry tariff minimum. They are not the same kind of number, so we do not average them or subtract one from another.
| Item | Figure | Context | Source |
|---|---|---|---|
| United States (advertised prices) | $7,480 mean (median $7,550; range $4,300–$11,800) | Advertised prices (peer-reviewed analysis of an aggregator dataset). A 2026 paper in Aesthetic Surgery Journal Open Forum (Güler et al.) analysed advertised prices across 100 US metropolitan areas; breast augmentation has 100 city observations. The authors describe the figures as bundled, consumer-facing advertised prices rather than itemized costs, and say they should not be read as standardized or audited cost structures. The underlying dataset, an aggregator's data hosted on Kaggle (accessed November 2025), has primary collection methods that are not publicly documented. This is what clinics advertise, not a measured total cost. | Güler et al., Aesthetic Surgery Journal Open Forum 2026 (Table 1) |
| United States (surgeon's fee) | $4,575–$8,000 (ASPS, 2024) | Surgeon's fee only — trade-body figure. ASPS publishes a projected range for implant placement (primary and/or revisions), based on averages submitted by surveyed members, for 2024. The Aesthetic Society reports an average for breast augmentation with implants from its 2022 national databank; the society itself says its figures reflect standard procedure costs (surgeon and facility fees) and may not include anesthesia, medical tests, prescriptions or surgical garments. Both are professional bodies of the surgeons who perform the operation, not independent measurements. | ASPS 2024 average surgeon/physician fees (statistics release, via Wayback Machine copy) · The Aesthetic Society, average plastic surgery costs (2022 data) |
| United Kingdom | £3,500–£8,000 (NHS website estimate, page reviewed Sept 2023) | NHS website estimate, page reviewed Sept 2023: the NHS says breast implant surgery in the UK costs around £3,500 to £8,000 and that this does not usually include consultations or follow-up care. The same page says breast enlargement cannot usually be had on the NHS, with some exceptions, for example very uneven breasts or no breasts. The NHS gives no data year for the range. | NHS.uk, Breast enlargement (page reviewed 21 September 2023) · NHS.uk, Is cosmetic surgery available on the NHS? |
| Germany (statutory insurance) | No price source; coverage only for medically necessary treatment | We found no official German total-price source for this operation. On coverage: statutory insurance (GKV) pays for treatment that is necessary to detect or cure an illness, prevent it from getting worse or relieve symptoms (§ 27 Abs. 1 SGB V). The consumer-advice body Verbraucherzentrale states that statutory insurers pay nothing for aesthetic operations that are not medically necessary (page dated 14 September 2026). In a 2004 decision on breast enlargement (BSG, 19 October 2004, B 1 KR 3/03 R) the Federal Social Court held that not every physical irregularity counts as an illness: there must be an impairment of body function or a disfiguring deviation. If an insured person develops an illness after a medically non-indicated aesthetic operation, the insurer must make them share the cost “in angemessener Höhe” (in a reasonable amount) (§ 52 Abs. 2 SGB V). Planned treatment outside the EU, EEA and Switzerland is, as a rule, not reimbursed (§ 13 Abs. 4 SGB V). | § 27, § 52, § 13 SGB V (buzer.de) · BSG, 19.10.2004, B 1 KR 3/03 R · Verbraucherzentrale (14 Sep 2026) |
| Turkey (ministry tariff minimum) | 50,000 lira (≈ $1,001) — Ministry of Health tariff minimum for international patients (2026), implant price excluded | Item SP603610 “Büyütme mammoplastisi, iki taraf” (breast augmentation, both sides) in the Ministry of Health's EK-2 price tariff (version of 28.07.2026; in force since 23.02.2026). The tariff sets the base price for health-tourism patients in public and private facilities, so this is the Ministry of Health's minimum price for international patients for this one line — a floor, not a package and not a quote. The implant price is excluded, and we do not add other tariff lines together. Converted at the ECB rate of October 30, 2026 (1 US dollar = 49.9476 lira; our calculation). | Turkey, Ministry of Health EK-2 price tariff (28.07.2026) · EK-1 usage rules, § 12(a) · ECB rate, 30 Oct 2026 |
| Turkey, Mexico, Greece, Thailand (package prices) | No citable package price | We found no official tariff and no peer-reviewed price study for a destination package in Turkey, Mexico, Greece or Thailand. Prices that clinics and agencies advertise online are marketing and are not used here. The Turkish ministry minimum above is the only official destination figure we found. | Source audit, 28 Oct 2026 |
| The catch — the second bill | £1,058–£19,549 per patient | Costs to the NHS of treating complications after elective surgery abroad (metabolic/bariatric, cosmetic and eye surgery together), in 2024 prices; certainty of the evidence is very low. The review identified 35 case series and case reports plus two surveys of NHS plastic surgeons, describing 655 patients treated between 2006 and 2024, of whom 265 had cosmetic surgery. Turkey was the most common destination (61%), and for cosmetic surgery tourism infection and wound dehiscence were most commonly reported. | England et al., BMJ Open 2026 (rapid review) |
| The catch — breast surgery abroad | Infection 39%; implants removed in 39% | A systematic review of aesthetic breast surgery done abroad (2021) pooled 171 patients with 222 complications: wound infection in 39%, and removal of the implant (explantation) in 39% (n = 32) of implant-based augmentation patients; infective complications and return-to-theatre rates were significantly higher than expected. The data come from retrospective case series without comparison groups, which the authors acknowledge. A UK hospital series of 19 patients treated in 2007–2009, mostly breast augmentation (13), reported NHS treatment costs of £120,841 for 11 patients (mean £6,360 across all 19, range £114–£57,968). | McCrossan et al., Aesthetic Plast Surg 2021 · Miyagi et al., J Plast Reconstr Aesthet Surg 2012 |
| The catch — what hospitals report | 81 patients, £755,559.68 (NHS Scotland, 2019–2023) | An NHS Scotland plastic surgery unit saw 81 patients over five years with complications of cosmetic surgery tourism (all procedures, not breast alone): wound dehiscence 49.4%, wound infection 24.7%; total cost £755,559.68, an average of £9,327.90 per patient. A Swiss hospital series of 228 patients with complications after aesthetic surgery in foreign countries found that breast surgery was the most frequent procedure (60%) and put the cost to the healthcare system at $795,574 for the observed period. A US CDC report on travel-related cosmetic procedures (2014–2024) described 21 consultations involving ≈145 patients, with liposuction (12), abdominoplasty (9) and other procedures; it is an infection-focused log, not an incidence study. | Roberts et al., The Surgeon 2024 · Hummel et al., Swiss Med Wkly 2023 · McNamara et al., Emerg Infect Dis 2026 |
| The catch — a trade-body audit | 324 patients in four years (BAAPS, 2022) | The British Association of Aesthetic Plastic Surgeons reported 324 patients requiring surgery after returning to the UK in the past four years, with the annual number up 44% in 2021. In its member survey, 100% of complications came from Turkey, and abdominoplasty accounted for 75% of complications, followed by breast surgery procedures at 25%. This is a press release by the trade body of private UK surgeons, based on a survey of its council members — use with caution. | BAAPS audit press release, 19 April 2022 |
| The catch — implants are not lifetime devices | Reoperation 31.5% at 10 years (manufacturer-sponsored study) | The US FDA states that breast implants are not considered lifetime devices: the longer people have them, the greater the chance of complications, and some require more surgery. A ten-year manufacturer-sponsored study (industry-funded) reported rupture by patient of 8.6%, Baker grade III/IV capsular contracture of 13.5% and reoperation of 31.5%. The NHS says some women may need further surgery after about 10 years. This applies wherever the operation is done. | US FDA, risks and complications of breast implants · Stevens et al., Plast Reconstr Surg 2018 · NHS.uk, Breast enlargement |
We compare prices; we don't tell anyone to travel or to stay home. Breast augmentation is a personal decision, and the right call depends on a conversation with your own surgeon — not on a gap between two numbers in a table.
The table has four kinds of price and one kind of risk figure. Reading them correctly matters more than the size of any single number.
The US mean of $7,480 comes from advertised, consumer-facing prices collected by an aggregator; the paper's authors say plainly that they are not itemized or audited. The surgeon's-fee figures from ASPS and The Aesthetic Society cover the surgeon's fee and, in the society's case, may leave out anesthesia, tests, prescriptions and garments. The NHS estimate states no data year. Put side by side, these are four different measurements, not four estimates of the same thing.
The 50,000-lira line is the Ministry of Health's minimum price for international patients for breast augmentation, both sides, in a tariff that applies to public and private facilities. It excludes the implant, it covers one line of a tariff rather than a package with flights, stay, anesthesia or follow-up, and we do not add other lines to it. It tells you where an official price floor sits; it does not tell you what a private hospital will charge you. No source we could cite does.
Every risk figure in the table comes from patients who came back with a problem, so none of them is a complication rate per operation abroad. What they do show is who pays next: in the UK data we found, the NHS, at £1,058 to £19,549 per patient in 2024 prices (very low certainty), with Turkey the most common destination (61% of the 655 patients in the review). The NHS also warns that overseas clinics may not provide follow-up treatment to the same standard, that travel insurance does not normally cover things going wrong in surgery, and that you should not fly for 5 to 7 days after procedures such as breast surgery.
Whatever the price, an implant may need replacing. The FDA says breast implants are not lifetime devices, and a ten-year manufacturer-sponsored study reported a 31.5% reoperation rate. A revision is a separate bill, and it is worth asking where it would be done and who would do it.
Advertised prices (peer-reviewed analysis of an aggregator dataset) put the mean at $7,480, with a median of $7,550 and a range of $4,300 to $11,800 across 100 US metropolitan areas (Güler et al., 2026). The surgeon's fee alone, from trade bodies, is $4,575 to $8,000 for 2024 (ASPS projected range). These measure different things: the first is what clinics advertise, the second is the surgeon's fee only, and neither is an audited total.
The NHS website estimates that breast implant surgery in the UK costs around £3,500 to £8,000, usually excluding consultations and follow-up care (page reviewed September 2023). The NHS says you cannot usually get breast enlargement on the NHS, with some exceptions, for example if you have very uneven breasts or no breasts.
There is a Ministry of Health tariff minimum for international patients (2026): item SP603610, breast augmentation both sides, 50,000 lira, which is about $1,001 at the ECB rate of October 30, 2026 (our calculation). The implant price is excluded, and it is a floor for that procedure line, not a package price and not a quote. We found no citable package price for Turkey, Mexico, Greece or Thailand, and we state none.
Statutory insurance pays for treatment that is necessary to detect or cure an illness, prevent it from getting worse or relieve symptoms (§ 27 Abs. 1 SGB V); aesthetic operations that are not medically necessary are not covered. In a 2004 breast-enlargement case the Federal Social Court required an impairment of body function or a disfiguring deviation (B 1 KR 3/03 R, 19 October 2004). If a complication follows a medically non-indicated aesthetic operation, the insurer must make the patient share the cost in a reasonable amount (§ 52 Abs. 2 SGB V). For planned treatment outside the EU, EEA and Switzerland, reimbursement is, as a rule, not available (§ 13 Abs. 4 SGB V).
Less than the headlines suggest. A 2026 rapid review said that without data on the number of operations performed, the risk of seeking surgery abroad cannot be fully understood: the studies we found count only patients who came back, so complication rates per operation abroad are not known. The case series that exist report, for example, wound infection in 39% and implant removal in 39% of implant-based augmentation patients in a pooled review (171 patients), and costs to the NHS of £1,058 to £19,549 per patient (2024 prices, very low certainty). The NHS advises not flying for 5 to 7 days after procedures such as breast surgery, and notes that travel insurance does not normally cover it if things go wrong in surgery. This is a cost comparison, not medical advice; consult a licensed provider.
Wellness Vision does not book trips, receive clinic referrals, or recommend specific providers, and we name none. Prices are labelled by type and source: advertised prices, a surgeon's fee, an NHS website estimate and a Ministry of Health tariff minimum are different things, and we state no package price for Turkey, Mexico, Greece or Thailand because we found none we can cite. Risk figures come from the peer-reviewed studies and official pages listed above. This is a cost comparison, not medical advice — consult a qualified, licensed provider before any decision.
📋 Or get the free Medical Travel Cost Checklist — no email →
You shouldn't have to go broke to feel whole.
